James Biagi
Impact in
- Oncology top 2%
- Colorectal Cancer Surgical Treatments
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Screening and Detection
- Reproductive Medicine top 2%
- Ovarian cancer diagnosis and treatment
Papers in
- Oncology 41
- Colorectal Cancer Treatments and Studies 23
- Pancreatic and Hepatic Oncology Research 17
- Colorectal Cancer Surgical Treatments 9
- Hepatology 10
- Hepatocellular Carcinoma Treatment and Prognosis 10
- Co-authors
- William J. MackillopChristopher M. BoothMichael J. RaphaelWeidong KongWill D. KingJohn F. SeymourAmit M. OzaElizabeth A. Eisenhauer
- Journals
- Journal of Clinical Oncology (23 papers)Gynecologic Oncology (3 papers)Clinical Oncology (3 papers)Cancer (2 papers)Investigational New Drugs (2 papers)
- Partner nations
- CanadaUnited StatesAustralia
In The Last Decade
James Biagi
61 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 93
- Oncology 1.2k
- Reproductive Medicine 336
- Hepatology 179
- Pathology and Forensic Medicine 376
- Obstetrics and Gynecology 161
Countries citing papers authored by James Biagi
This map shows the geographic impact of James Biagi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Biagi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Biagi more than expected).
Fields of papers citing papers by James Biagi
This network shows the impact of papers produced by James Biagi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Biagi. The network helps show where James Biagi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside James Biagi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 15 | |
| 2 | 2018 | 4 | |
| 3 | 2017 | 7 | |
| 4 | 2017 | 18 | |
| 5 | 2017 | 58 | |
| 6 | 2016 | 102 | |
| 7 | 2016 | 30 | |
| 8 | 2016 | 12 | |
| 9 | 2016 | 8 | |
| 10 | 2015 | 15 | |
| 11 | 2015 | 6 | |
| 12 | 2013 | 52 | |
| 13 | 2012 | 47 | |
| 14 | 2012 | 82 | |
| 15 | Association Between Time to Initiation of Adjuvant Chemotherapy and Survival in Colorectal Cancer Hit paper breakdown → | 2011 | 463 |
| 16 | 2008 | 55 | |
| 17 | A Phase 2 study of AZD2171 in recurrent or persistent ovarian, peritoneal or fallopian tube cancer. A study of the PMH, Chicago, and California Phase II Consortia | 2007 | 1 |
| 18 | 2007 | 4 | |
| 19 | 2007 | 29 | |
| 20 | 2005 | 8 |
About James Biagi
James Biagi is a scholar working on Oncology, Hepatology, Cancer Research, Reproductive Medicine and Pulmonary and Respiratory Medicine, having authored 61 papers that have together received 1.9k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (23 papers), Pancreatic and Hepatic Oncology Research (17 papers), Gastric Cancer Management and Outcomes (14 papers), Hepatocellular Carcinoma Treatment and Prognosis (10 papers), Colorectal Cancer Surgical Treatments (9 papers), Ovarian cancer diagnosis and treatment (8 papers), Cancer Genomics and Diagnostics (8 papers) and Renal cell carcinoma treatment (6 papers). The work is most often cited by research in Oncology (1.2k citations), Reproductive Medicine (336 citations), Hepatology (179 citations), Pathology and Forensic Medicine (376 citations) and Obstetrics and Gynecology (161 citations). James Biagi has collaborated with scholars based in Canada, United States and Australia. Frequent co-authors include William J. Mackillop, Christopher M. Booth, Michael J. Raphael, Weidong Kong, Will D. King, John F. Seymour, Amit M. Oza, Elizabeth A. Eisenhauer, Hal W. Hirte and Christopher M. Booth. Their work appears in journals such as Journal of Clinical Oncology, Gynecologic Oncology, Clinical Oncology, Cancer and Investigational New Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.